Theravance Biopharma Inc (TBPH)

09:47 AM

Does Theravance Bio (TBPH) Have the Potential to Rally 30.64% as Wall Street Analysts Expect? - Zacks Investment Research

09:47 AM

03:11 AM

How Theravance Biopharma Inc. (0TB) stock reacts to fiscal policiesBond Market & Long-Term Safe Investment Plans - Newser

03:11 AM

01:41 AM

Why Theravance Biopharma Inc. (0TB) stock attracts HNW investorsJuly 2025 Price Swings & Advanced Technical Analysis Signals - Newser

01:41 AM

Dec 04, 2025

Is Theravance Biopharma Inc. stock ready for breakoutEarnings Performance Report & Free Real-Time Market Sentiment Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Oppenheimer Initiates Coverage of Theravance Biopharma (TBPH) with Outperform Recommendation - Nasdaq

Dec 03, 2025

Dec 03, 2025

VP Farnum Files To Sell 31,067 Of Theravance Biopharma Inc [TBPH] - TradingView

Dec 03, 2025

Dec 03, 2025

Oppenheimer Initiates Coverage on TBPH with Outperform Rating | - GuruFocus

Dec 03, 2025

Dec 03, 2025

Oppenheimer Initiates Theravance Biopharma at Outperform With $27 Price Target - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Oppenheimer initiates Theravance Biopharma stock with Outperform rating - Investing.com

Dec 03, 2025

Dec 03, 2025

Oppenheimer initiates Theravance Biopharma stock with Outperform rating By Investing.com - Investing.com Canada

Dec 03, 2025

Dec 02, 2025

Market Trends: Will Theravance Biopharma Inc stock maintain momentum in 2025July 2025 Spike Watch & Consistent Return Investment Signals - BỘ NỘI VỤ

Dec 02, 2025

Dec 02, 2025

Why analysts recommend Theravance Biopharma Inc. (0TB) stockWeekly Profit Report & Growth Focused Investment Plans - Newser

Dec 02, 2025

Dec 01, 2025

Will Theravance Biopharma Inc. stock maintain momentum in 20252025 AllTime Highs & Accurate Trade Setup Notifications - Newser

Dec 01, 2025

Dec 01, 2025

Dir Broshy Sells 29,501 ($590K) Of Theravance Biopharma Inc [TBPH] - TradingView

Dec 01, 2025

Dec 01, 2025

Trading Systems Reacting to (TBPH) Volatility - news.stocktradersdaily.com

Dec 01, 2025

Nov 28, 2025

Theravance Biopharma stock hits 52-week high at 20.29 USD By Investing.com - Investing.com Nigeria

Nov 28, 2025

Nov 28, 2025

How Theravance Biopharma Inc. stock reacts to global recession fearsTrade Volume Report & Risk Managed Investment Signals - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Theravance Biopharma stock hits 52-week high at 20.29 USD - Investing.com

Nov 28, 2025

Nov 28, 2025

Aug Movers: Will Theravance Biopharma Inc. stock outperform Dow Jones index2025 Geopolitical Influence & Short-Term High Return Ideas - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Why Theravance Biopharma Inc. stock could outperform in 2025Weekly Risk Report & Daily Chart Pattern Signal Reports - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Theravance Biopharma (NASDAQ:TBPH) Shares Gap Up Following Analyst Upgrade - MarketBeat

Nov 27, 2025

Nov 27, 2025

Theravance Biopharma, Inc. $TBPH Shares Acquired by Jefferies Financial Group Inc. - MarketBeat

Nov 27, 2025

Nov 26, 2025

BTIG Maintains Theravance Biopharma (TBPH) Buy Recommendation - MSN

Nov 26, 2025

Nov 26, 2025

Dir Broshy Files To Sell 29,501 Of Theravance Biopharma Inc [TBPH] - TradingView

Nov 26, 2025

Nov 26, 2025

TBPH: BTIG Raises Price Target to $40 While Maintaining Buy Rati - GuruFocus

Nov 26, 2025

Nov 26, 2025

Theravance Biopharma (NASDAQ:TBPH) Reaches New 12-Month HighHere's What Happened - MarketBeat

Nov 26, 2025

Nov 24, 2025

[Form 4] Theravance Biopharma, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025

Nov 24, 2025

CFO Sawaf Surrenders 18,627 Of Theravance Biopharma Inc [TBPH] - TradingView

Nov 24, 2025

Nov 24, 2025

TBPH insider filing: CFO tax-withholding of 18,627 shares at $17.90 - Stock Titan

Nov 24, 2025

Nov 24, 2025

VP Miller Surrenders 6,989 Of Theravance Biopharma Inc [TBPH] - TradingView

Nov 24, 2025

Nov 24, 2025

VP Farnum Surrenders 9,060 Of Theravance Biopharma Inc [TBPH] - TradingView

Nov 24, 2025

Nov 22, 2025

Theravance's Q3 Earnings Surpass Estimates, Revenues Match - MSN

Nov 22, 2025

Nov 21, 2025

CEO Winningham Surrenders 56,817 Of Theravance Biopharma Inc [TBPH] - TradingView

Nov 21, 2025

Nov 21, 2025

Can Theravance Biopharma Inc. stock beat analyst upgrades - newser.com

Nov 21, 2025

Nov 21, 2025

Why pension funds invest in Theravance Biopharma Inc. (0TB) stock2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com

Nov 21, 2025

Nov 21, 2025

Is Theravance Biopharma Inc. stock attractive for passive investors2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Theravance Biopharma (TBPH) is a Top-Ranked Growth Stock: Should You Buy? - MSN

Nov 21, 2025

Nov 21, 2025

Why Theravance Biopharma Inc. stock is rated strong buy2025 Fundamental Recap & Accurate Trade Setup Notifications - newser.com

Nov 21, 2025

Nov 20, 2025

Theravance Biopharma to host virtual KOL event on ampreloxetine study By Investing.com - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Theravance Biopharma to host virtual KOL event on ampreloxetine study - Investing.com

Nov 20, 2025

Nov 20, 2025

Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025 - 富途牛牛

Nov 20, 2025

Nov 20, 2025

Is Theravance Biopharma Inc. (0TB) stock a fit for income portfoliosJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com

Nov 20, 2025

Nov 19, 2025

Theravance Biopharma Inc. stock trendline breakdownQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com

Nov 19, 2025